Yanmei Cui et al. reported that, in breast cancer, PTOV1 enhanced CSCs population by recruiting HDAC1/2 to reduce DKK1 promoter histone acetylation and subsequently activating Wnt/β-catenin signaling [21]. This evidence concerns the gene PTOV1 and breast cancer.